| 1. | | Recruiting | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
Conditions: recurrent neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma; localized resectable neuroblastoma; regional neuroblastoma; ... |
| 2. | | Recruiting | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Conditions: localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; ... |
| 3. | | Recruiting | Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
Conditions: localized unresectable neuroblastoma; disseminated neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma |
| 4. | | Recruiting | Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Conditions: disseminated neuroblastoma; localized unresectable neuroblastoma; recurrent neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma |
| 5. | | Recruiting | Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Patients With Neuroblastoma
Conditions: localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma |
| 6. | | Recruiting | Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
Conditions: regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized resectable neuroblastoma; localized unresectable neuroblastoma |
| 7. | | Recruiting | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma
Conditions: localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma |
| 8. | | Recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Conditions: localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma |
| 9. | | Recruiting | Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Conditions: regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma |
| 10. | | Recruiting | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
Conditions: regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma |
| 11. | | Recruiting | Combination Chemotherapy in Treating Children With Neuroblastoma
Conditions: regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma |
| 12. | | Not yet recruiting | Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
Conditions: Ewing's family of tumors; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood rhabdomyosarcoma; Neuroblastoma |
| 13. | | Recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
Conditions: childhood brain tumor; childhood rhabdoid tumor of the central nervous system; childhood rhabdomyosarcoma; childhood spinal cord tumors; ... |
| 14. | | Recruiting | Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplantation in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Conditions: childhood brain tumor; childhood rhabdoid tumor of the central nervous system; Neuroblastoma |
| 15. | | Recruiting | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Conditions: Ewing's family of tumors; adult solid tumor; childhood brain tumor; childhood solid tumor; Gastrointestinal Cancer; Neuroblastoma |
| 16. | | Recruiting | Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors
Conditions: childhood brain tumor; Neuroblastoma |
| 17. | | Recruiting | Investigating the Use of Interleukin-12 and Interleukin-2 to Treat Children with Neuroblastoma
Condition: Neuroblastoma |
| 18. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma |
| 19. | | Recruiting | Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma |
| 20. | | Recruiting | Monoclonal Antibody Therapy After Allogeneic Stem Cell Transplantation in Treating Patients With Persistent or Progressive Cancer
Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; hematopoietic and lymphoid cancer; Neuroblastoma |
| 21. | | Recruiting | Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Conditions: Diarrhea; Drug Toxicity; disseminated neuroblastoma; recurrent neuroblastoma |
| 22. | | Recruiting | CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
Conditions: recurrent neuroblastoma; disseminated neuroblastoma |
| 23. | | Recruiting | Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Conditions: recurrent neuroblastoma; disseminated neuroblastoma |
| 24. | | Recruiting | beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Conditions: disseminated neuroblastoma; recurrent neuroblastoma |
| 25. | | Recruiting | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
Conditions: disseminated neuroblastoma; stage 4S neuroblastoma |
| 26. | | Recruiting | Surgery in Treating Patients With Neuroblastoma
Conditions: localized resectable neuroblastoma; localized unresectable neuroblastoma |
| 27. | | Recruiting | Surgery in Treating Children With Neuroblastoma
Conditions: localized resectable neuroblastoma; stage 4S neuroblastoma |
| 28. | | Recruiting | Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
Condition: Neuroblastoma |
| 29. | | Recruiting | CHP677: I-Metaiodobenzylguanidine (I-MIBG) therapy for refractory neuroblastoma: a Phase II study
Condition: Neuroblastoma |
| 30. | | Recruiting | Irinotecan in Treating Children With Refractory Solid Tumors
Conditions: Ewing's family of tumors; childhood brain tumor; childhood rhabdomyosarcoma; childhood solid tumor; Neuroblastoma; Osteosarcoma |
| 31. | | Recruiting | P-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors
Conditions: Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma |
| 32. | | Recruiting | Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation in Treating Patients With Refractory Neuroblastoma
Condition: recurrent neuroblastoma |
| 33. | | Not yet recruiting | hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Condition: recurrent neuroblastoma |
| 34. | | Recruiting | Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma
Conditions: unspecified childhood solid tumor, protocol specific; recurrent neuroblastoma |
| 35. | | Recruiting | Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma
Condition: recurrent neuroblastoma |
| 36. | | Recruiting | Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
Condition: recurrent neuroblastoma |
| 37. | | Recruiting | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma
Condition: disseminated neuroblastoma |
| 38. | | Recruiting | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.
Condition: localized unresectable neuroblastoma |
| 39. | | Recruiting | Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma
Condition: localized unresectable neuroblastoma |
| 40. | | Recruiting | Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
Condition: recurrent neuroblastoma |
| 41. | | Recruiting | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Condition: childhood cancer |
| 42. | | Recruiting | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Conditions: Fanconi's Anemia; Cancer |
| 43. | | Recruiting | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
Condition: Cancer |
| 44. | | Recruiting | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Condition: Cancer |
| 45. | | Recruiting | Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy |
| 46. | | Recruiting | Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Cancer; Infection |
| 47. | | Recruiting | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
Condition: childhood cancer |
| 48. | | Recruiting | Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy; Pain |
| 49. | | Recruiting | Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition: Cancer |
| 50. | | Recruiting | ABT-751 in Treating Young Patients With Refractory Solid Tumors
Condition: childhood cancer |
